Page last updated: 2024-10-22

altretamine and Glioma

altretamine has been researched along with Glioma in 1 studies

Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stewart, DJ1
Benvenuto, JA1
Leavens, M1
Smith, RG1
Cabanillas, F1
Benjamin, RS1
Loo, TL1

Other Studies

1 other study available for altretamine and Glioma

ArticleYear
Human central nervous system pharmacology of pentamethylmelamine and its metabolites.
    Journal of neuro-oncology, 1983, Volume: 1, Issue:4

    Topics: Altretamine; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Glioma; Humans; Kinetics;

1983